Protein Dynamic Solutions

About:

Biotherapeutics Analytical Instrumentation for AI, R&D and Manufacturing [ HT multi-attribute multi-variate (MAM) and label free analysis].

Website: https://pdsbio.com

Twitter/X: proteinds

Top Investors: National Science Foundation

Description:

PDS’ ProteinMentor ™ is a breakthrough platform technology for biopharma allowing real-time monitoring of an array of proteins in solution during gentle perturbation to assess Critical Quality Attributes (CQAs) providing insights into formulation optimization, stability, charge variance, proteinaceous particle generation propensity, as well as detecting sample contamination by bacteria or other foreign organisms. ProteinMentor software platform uses Quantum Cascade Laser Infrared (QCL IR) microscopy -200x faster than existing FT-IR - for deep real-time proteins in solution analysis and an innovative slide cell array for evaluation of CQA’s across candidate selection, drug design and manufacturing product release-testing. ProteinMentor's capabilities are enabled by unprecedented HT multi-attribute multi-variate (MAM) and label free analysis of proteins in solution (drug product/drug substance) without formulation limitations.

Total Funding Amount:

$4.27M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Wakefield, Massachusetts, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)pdsbio.com

Founders:

Belinda Pastrana, Emilio Rivera, William Lockwood Benet

Number of Employees:

1-10

Last Funding Date:

2019-04-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai